{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1362825895153661952.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.1073/pnas.0606857103"}},{"identifier":{"@type":"URI","@value":"https://pnas.org/doi/pdf/10.1073/pnas.0606857103"}},{"identifier":{"@type":"NAID","@value":"30016303332"}}],"dc:title":[{"@value":"Bone morphogenetic protein antagonist gremlin 1 is widely expressed by cancer-associated stromal cells and can promote tumor cell proliferation"}],"description":[{"type":"abstract","notation":[{"@value":"<jats:p>\n            Although tissue microenvironments play critical roles in epithelial development and tumorigenesis, the factors mediating these effects are poorly understood. In this work, we used a genomic approach to identify factors produced by cells in the microenvironment of basal cell carcinoma (BCC) of the skin, one of the most common human cancers. The global gene expression programs of stromal cell cultures derived from human BCCs showed consistent, systematic differences from those derived from nontumor skin. The gene most consistently expressed at a higher level in BCC tumor stromal cells compared with those from nontumor skin was\n            <jats:italic>GREMLIN 1</jats:italic>\n            , which encodes a secreted antagonist of the bone morphogenetic protein (BMP) pathway. BMPs and their antagonists are known to play a crucial role in stem and progenitor cell biology as regulators of the balance between expansion and differentiation. Consistent with the hypothesis that BMP antagonists might have a similar role in cancer, we found\n            <jats:italic>GREMLIN 1</jats:italic>\n            expression in the stroma of human BCC tumors but not in normal skin\n            <jats:italic>in vivo</jats:italic>\n            . Furthermore, BMP 2 and 4 are expressed by BCC cells.\n            <jats:italic>Ex vivo</jats:italic>\n            , BMP inhibits, and Gremlin 1 promotes, proliferation of cultured BCC cells. We further found that\n            <jats:italic>GREMLIN 1</jats:italic>\n            is expressed by stromal cells in many carcinomas but not in the corresponding normal tissue counterparts that we examined. Our data suggest that BMP antagonists may be important constituents of tumor stroma, providing a favorable microenvironment for cancer cell survival and expansion in many cancers.\n          </jats:p>"}]}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1380857672118306439","@type":"Researcher","foaf:name":[{"@value":"Julie B. Sneddon"}],"jpcoar:affiliationName":[{"@value":"Departments of *Biochemistry,"}]},{"@id":"https://cir.nii.ac.jp/crid/1380857672118306433","@type":"Researcher","foaf:name":[{"@value":"Hanson H. Zhen"}],"jpcoar:affiliationName":[{"@value":"Dermatology, and"}]},{"@id":"https://cir.nii.ac.jp/crid/1380857672118306436","@type":"Researcher","foaf:name":[{"@value":"Kelli Montgomery"}],"jpcoar:affiliationName":[{"@value":"Pathology, and"}]},{"@id":"https://cir.nii.ac.jp/crid/1380857672118306442","@type":"Researcher","foaf:name":[{"@value":"Matt van de Rijn"}],"jpcoar:affiliationName":[{"@value":"Pathology, and"}]},{"@id":"https://cir.nii.ac.jp/crid/1380857672118306441","@type":"Researcher","foaf:name":[{"@value":"Aaron D. Tward"}],"jpcoar:affiliationName":[{"@value":"G. W. Hooper Foundation, University of California, San Francisco, CA 94143"}]},{"@id":"https://cir.nii.ac.jp/crid/1380857672118306434","@type":"Researcher","foaf:name":[{"@value":"Robert West"}],"jpcoar:affiliationName":[{"@value":"Pathology, and"}]},{"@id":"https://cir.nii.ac.jp/crid/1380857672118306435","@type":"Researcher","foaf:name":[{"@value":"Hayes Gladstone"}],"jpcoar:affiliationName":[{"@value":"Dermatology, and"}]},{"@id":"https://cir.nii.ac.jp/crid/1380857672118306432","@type":"Researcher","foaf:name":[{"@value":"Howard Y. Chang"}],"jpcoar:affiliationName":[{"@value":"Dermatology, and"}]},{"@id":"https://cir.nii.ac.jp/crid/1380857672118306440","@type":"Researcher","foaf:name":[{"@value":"Greg S. Morganroth"}],"jpcoar:affiliationName":[{"@value":"Dermatology, and"}]},{"@id":"https://cir.nii.ac.jp/crid/1380857672118306437","@type":"Researcher","foaf:name":[{"@value":"Anthony E. Oro"}],"jpcoar:affiliationName":[{"@value":"Dermatology, and"}]},{"@id":"https://cir.nii.ac.jp/crid/1380857672118306438","@type":"Researcher","foaf:name":[{"@value":"Patrick O. Brown"}],"jpcoar:affiliationName":[{"@value":"Departments of *Biochemistry,"},{"@value":"Howard Hughes Medical Institute, Stanford University Medical Center, Stanford, CA 94305; and"}]}],"publication":{"publicationIdentifier":[{"@type":"PISSN","@value":"00278424"},{"@type":"EISSN","@value":"10916490"}],"prism:publicationName":[{"@value":"Proceedings of the National Academy of Sciences"}],"dc:publisher":[{"@value":"Proceedings of the National Academy of Sciences"}],"prism:publicationDate":"2006-10-03","prism:volume":"103","prism:number":"40","prism:startingPage":"14842","prism:endingPage":"14847"},"reviewed":"false","url":[{"@id":"https://pnas.org/doi/pdf/10.1073/pnas.0606857103"}],"createdAt":"2006-09-27","modifiedAt":"2022-04-12","relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1050564288768511744","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Cancer-associated fibroblasts in gastrointestinal cancer"}]},{"@id":"https://cir.nii.ac.jp/crid/1050846637266188672","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Directed Differentiation of Patient-Specific Induced Pluripotent Stem Cells Identifies the Transcriptional Repression and Epigenetic Modification of NKX2-5, HAND1, and NOTCH1 in Hypoplastic Left Heart Syndrome"}]},{"@id":"https://cir.nii.ac.jp/crid/1360002216818402944","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Transforming growth factor-β decreases the cancer-initiating cell population within diffuse-type gastric carcinoma cells"}]},{"@id":"https://cir.nii.ac.jp/crid/1360283690826919552","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Bone Marrow-Derived Myofibroblasts Contribute to the Mesenchymal Stem Cell Niche and Promote Tumor Growth"}]},{"@id":"https://cir.nii.ac.jp/crid/1360567186305208832","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Gremlin, a Bone Morphogenetic Protein Antagonist, Is a Crucial Angiogenic Factor in Pituitary Adenoma"}]},{"@id":"https://cir.nii.ac.jp/crid/1360588381044915712","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Quantification of Gremlin 1 throughout the tumor stroma using whole slide imaging and its clinicopathological significance in gastric cancer"}]},{"@id":"https://cir.nii.ac.jp/crid/1360846640816403712","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Mechanisms of action of bone morphogenetic proteins in cancer"}]},{"@id":"https://cir.nii.ac.jp/crid/1360848659482012416","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"p53 functional deficiency in human colon cancer cells promotes fibroblast-mediated angiogenesis and tumor growth"}]},{"@id":"https://cir.nii.ac.jp/crid/1360848660745011840","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Bi‐directional roles of bone morphogenetic proteins in cancer: Another molecular Jekyll and Hyde?"}]},{"@id":"https://cir.nii.ac.jp/crid/1360853567761411840","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"The Balance of Stromal BMP Signaling Mediated by GREM1 and ISLR Drives Colorectal Carcinogenesis"}]},{"@id":"https://cir.nii.ac.jp/crid/1520009407484418304","@type":"Article","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@value":"The short toes mutation of the axoloti"},{"@language":"ja-Kana","@value":"The short toes mutation of the axoloti"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1073/pnas.0606857103"},{"@type":"CIA","@value":"30016303332"},{"@type":"CROSSREF","@value":"10.1038/onc.2010.546_references_DOI_Nd9HsAUCbCPzYgqQUK7MmFvI5xb"},{"@type":"CROSSREF","@value":"10.1371/journal.pone.0102796_references_DOI_Nd9HsAUCbCPzYgqQUK7MmFvI5xb"},{"@type":"CROSSREF","@value":"10.1155/2015/834137_references_DOI_Nd9HsAUCbCPzYgqQUK7MmFvI5xb"},{"@type":"CROSSREF","@value":"10.1016/j.ccr.2011.01.020_references_DOI_Nd9HsAUCbCPzYgqQUK7MmFvI5xb"},{"@type":"CROSSREF","@value":"10.1007/s00428-024-03903-8_references_DOI_Nd9HsAUCbCPzYgqQUK7MmFvI5xb"},{"@type":"CROSSREF","@value":"10.1093/carcin/bgw085_references_DOI_Nd9HsAUCbCPzYgqQUK7MmFvI5xb"},{"@type":"CROSSREF","@value":"10.1111/pin.12067_references_DOI_Nd9HsAUCbCPzYgqQUK7MmFvI5xb"},{"@type":"CROSSREF","@value":"10.1053/j.gastro.2020.11.011_references_DOI_Nd9HsAUCbCPzYgqQUK7MmFvI5xb"},{"@type":"CROSSREF","@value":"10.1038/s41575-019-0115-0_references_DOI_Nd9HsAUCbCPzYgqQUK7MmFvI5xb"},{"@type":"CROSSREF","@value":"10.1016/j.cytogfr.2015.11.009_references_DOI_Nd9HsAUCbCPzYgqQUK7MmFvI5xb"}]}